Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley cautious

Cipla's partnership with Qilu Pharmaceutical for a Keytruda biosimilar is expected to strengthen its oncology and specialty ...